Hansen Gwenn bought NRIX
February 10, 2026 · Form 4 insider transaction
Hansen Gwenn bought 93,750 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
93,750
Price
$0.00
Total value
N/A
InsiderHansen Gwenn
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 10, 2026
Filing dateFebruary 10, 2026
Shares owned after93,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests as to 1/36 of the total shares monthly beginning March 10, 2026, until the option is fully vested on February 9, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date.